Physician profile
John Fischer
NPI 1245276310
$648.98
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $37.27 · 2021: $302 · 2022: $72.98 · 2023: $15.32 · 2024: $58.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $73.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $73.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $249.61 | 2021 | |
| Glaxosmithkline, LLC. | $223.37 | 2019-2024 | Bexsero |
| Kaleo, INC. | $80.29 | 2020-2023 | Auvi-Q |
| Merck Sharp & Dohme LLC | $38.77 | 2019-2022 | |
| Tris Pharma INC | $15.00 | 2022 | |
| Cranial Technologies, INC | $14.49 | 2022 | |
| Lilly USA, LLC | $14.12 | 2022 | |
| Sanofi Pasteur INC. | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.